Nihon Kohden Celebrates 10th Consecutive Donation to Epilepsy Research

Nov. 28, 2018 12:00 UTC

Company’s Annual Contributions to American Epilepsy Society Have Totaled More Than $250,000

IRVINE, Calif.--(BUSINESS WIRE)-- For the 10th consecutive year, Nihon Kohden has donated the proceeds from the sale of one of its EEG-1200A machines to the American Epilepsy Society’s (AES) clinical and basic research fellowships. The proceeds of the EEG system, which was purchased by Memorial Hermann Health System, will be presented to AES at 2 p.m. on Dec. 1 during the society’s annual meeting in New Orleans.

Nihon Kohden, a leader in epilepsy and neurology instrumentation, initiated the donation program a decade ago to foster future advancements in epilepsy diagnosis and treatment. Since its inception, the company has contributed more than $250,000 to AES’s research programs.

“Nihon Kohden’s gifts over the last 10 years have funded the promising epilepsy research of several new investigators,” said Shlomo Shinnar, American Epilepsy Society president. “Investment in early career researchers is a key priority for AES and represents an investment in the future of epilepsy research and the improvements in care for our patients. We appreciate Nihon Kohden’s commitment to research and are pleased to celebrate 10 years of continued partnership.”

Over the past decade, donations from Nihon Kohden have helped fund research into many significant areas, including the connection between epilepsy and traumatic brain injuries, the development of a neurophysiologic toolbox to aid in the diagnosis of epilepsy in patients with Alzheimer’s disease and how transcranial direct-current stimulation can improve memory and depression in epilepsy patients.

“Now, as ever, investment in a new generation of researchers is critical for the enhancement of new discovery and eventual translation to clinical care,” said Dr. Samden Lhatoo, McGovern Chair in epilepsy, University of Texas, Houston, and director of epilepsy and neurophysiology, Memorial Hermann Hospital. “Nihon Kohden’s ongoing support in this regard is much appreciated by the epilepsy community.”

Nihon Kohden’s support of AES is part of the organization’s fundraising efforts to support the society’s educational, research and training offerings. Proceeds will be designated to support postdoctoral fellowships and early career grants awarded through the Lennox & Lombroso Trust and a clinical research training fellowship awarded through the Susan S. Spencer Fund.

“Every member of the Nihon Kohden team is deeply invested in research being conducted by the AES and its fellowships,” said Kathy Hart, Nihon Kohden America vice president of alliances. “We are proud that we have been able to contribute to the advancement of the field of epilepsy, and we are grateful that Memorial Hermann Health System could be part of this momentous donation.”

About Nihon Kohden Corporation

Founded in Japan in 1951, Nihon Kohden is a leading manufacturer, developer and distributor of medical electronic equipment, with subsidiaries in the U.S., Europe and Asia. The company’s products are now used in more than 120 countries, and it is the largest supplier of electroencephalography products worldwide. A pioneer in transformational healthcare technology, Nihon Kohden has envisioned, designed and produced revolutionary devices, such as pulse oximeters, arrhythmia analysis, low-invasive blood volume monitoring and wireless patient monitoring. In the U.S., the company is a trusted source for patient monitoring, sleep assessment, neurology and cardiology instrumentation solutions, and has been rated No. 1 in patient monitoring or telemetry for more than 10 consecutive years (MD Buyline). For more information, visit us.nihonkohden.com.

MD Buyline is a registered service mark of MD Buyline.

Contacts

Julie Johnson
Senior Director, Communications and Public Relations
949-238-4869
Julie_johnson@nihonkohden.com

 
 

Source: Nihon Kohden Corporation

Back to news